← All guides

What are GLP-1 medications?

A plain-English explainer of the drug class that has reshaped diabetes and obesity treatment.

7 min read · Reviewed May 2026

GLP-1 medications are a class of injectable (and one oral) drugs that mimic a gut hormone called glucagon-like peptide-1. They were originally developed for type 2 diabetes, but turned out to cause substantial weight loss as a side effect — so substantial that several are now FDA-approved specifically for chronic weight management.

The short version

The drugs in this class

BrandGenericIndication
OzempicsemaglutideType 2 diabetes
WegovysemaglutideWeight management
Rybelsussemaglutide (oral)Type 2 diabetes
MounjarotirzepatideType 2 diabetes
ZepboundtirzepatideWeight management
SaxendaliraglutideWeight management
VictozaliraglutideType 2 diabetes
TrulicitydulaglutideType 2 diabetes

Tirzepatide is technically a dual GLP-1 / GIP agonist rather than a pure GLP-1, but it is conventionally grouped with the class.

Why the buzz?

Two reasons:

  1. Weight loss is real and substantial. Average weight loss with semaglutide in the STEP trials was ~15% of body weight. Tirzepatide hit ~21% in SURMOUNT-1 — territory previously only seen with bariatric surgery.
  2. Health outcomes are improving too. The SELECT trial showed semaglutide reduced major cardiovascular events by 20% in adults with obesity and existing heart disease. Renal benefits (FLOW), sleep apnea improvements, and even reduced alcohol cravings are emerging in newer data.

What they aren’t

Next steps

Educational content only — not medical advice. Always consult a licensed clinician before starting or changing GLP-1 therapy.